about
Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across ThailandCarbapenems: past, present, and futureCharacterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from IndiaStructural and Biochemical Evidence That a TEM-1 -Lactamase N170G Active Site Mutant Acts via Substrate-assisted CatalysisAnalysis of the Binding Forces Driving the Tight Interactions between -Lactamase Inhibitory Protein-II (BLIP-II) and Class A -LactamasesMutagenesis of Zinc Ligand Residue Cys221 Reveals Plasticity in the IMP-1 Metallo- -Lactamase Active SiteStructural Basis for Progression toward the Carbapenemase Activity in the GES Family of β-LactamasesIdentification and characterization of a novel aac(6')-Iag associated with the blaIMP-1-integron in a multidrug-resistant Pseudomonas aeruginosaEvolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.Structural and Functional Aspects of Class A Carbapenemases.Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study.Draft genome sequence of a GES-5-producing Serratia marcescens isolated in southern Brazil.High Prevalence of blaNDM-1, blaVIM, qacE, and qacEΔ1 Genes and Their Association with Decreased Susceptibility to Antibiotics and Common Hospital Biocides in Clinical Isolates of Acinetobacter baumanniiBench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae.Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.Epidemiology of VIM-1-imipenem resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysisThe changing epidemiology of resistance.OXA-198, an acquired carbapenem-hydrolyzing class D beta-lactamase from Pseudomonas aeruginosaEpidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.Current epidemiology and growing resistance of gram-negative pathogens.Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC).Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrix-assisted laser desorption ionization-time of flight mass spectrometryAntibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases worldB1-Metallo-β-Lactamases: Where Do We Stand?β-Lactamase production in key gram-negative pathogen isolates from the Arabian PeninsulaDetection of plasmid-mediated IMP-1 metallo-beta-lactamase and quinolone resistance determinants in an ertapenem-resistant Enterobacter cloacae isolate.Analysis of some common pathogens and their drug resistance to antibioticsDiversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.Gene cassettes and cassette arrays in mobile resistance integrons.Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.In vitro activity studies of doripenem and two other carbapenems tested against Pseudomonas aeruginosa and other non-fermentative bacilli.Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.Hydrolytic mechanism of OXA-58 enzyme, a carbapenem-hydrolyzing class D β-lactamase from Acinetobacter baumannii.Mass spectrometry methods for predicting antibiotic resistance.
P2860
Q21245791-0E43E1B9-8F9A-450B-97D3-A459F7886E2BQ24634999-D5C98BFE-B7E4-46D9-B7EA-80A28C379AE0Q24647709-C2411A0A-F251-4E41-9BA0-C52450B00423Q27657721-C0661407-87E1-48E4-BFC4-C79B5AD876D3Q27670891-7058E034-2F03-4730-9C2C-5DD192F09C07Q27671609-53909346-47D1-4CCF-A4E1-FBBEE7E1B6DAQ27675115-3AA54F07-E19A-445B-8715-0BCA243A7E3BQ28535259-5AF3E932-D751-44BE-A299-EDFD9844BB6EQ28752557-834F9B34-09FB-49D4-85CD-37496C1B3A2DQ33544102-5A41C837-970D-4E47-8C3B-219D86799F3DQ33604862-230CDE86-6156-422C-BE93-7F28B1271116Q33650700-43E8D506-093A-4017-AF98-B16EEB16D941Q33796439-F46ABF70-EAE5-4553-95A3-A22214F3A0D3Q33845360-CCCA492D-4720-4BF4-B880-8AEB5351222CQ34026758-FCAA51CC-668C-4C99-B3DF-709A743DE16BQ34046522-AD01BAF8-2879-4A24-89C6-F6870773D890Q34625178-BA6C6E84-D0D9-4BD0-8A79-89B6C6C1EA95Q34716069-C7F874E4-A244-4FAD-9590-2ED1C5FEF46FQ34997021-3015E4A0-F95C-4EFD-AF83-73C4422AA626Q35270559-CDA9F170-2695-48CA-8810-83AA7EAEA6C0Q35829646-A7DDD4A5-8B9E-44F3-89A5-F69044603385Q36025192-FBE3A463-D17B-4369-8BC0-FD9341AD59C2Q36171410-54D2D37E-7A98-4834-BF97-E8A32F4544F5Q36506376-4E61B2D7-C124-4074-9DD4-E17957838E0AQ36595848-C8C2D64D-9E0C-47A3-A8D0-8673E2A79B6BQ36746608-911DDB56-4E0B-4059-A9B5-16ED3845F240Q37035803-D1C65F6E-B727-4F5C-B828-DE3491AB9D0FQ37177466-9CCF8CAB-C1FD-4047-870D-6D755E2400B2Q37257836-95615686-4246-42CB-83FF-87D45EC317ABQ37333114-8BE6CFE2-D527-46EA-96E5-09AFE31E5CCAQ37410429-2A53A30A-8A7D-4DE1-9759-32E8A0B2C57AQ37470852-52A2F044-23E6-4874-8ABD-9DC05A31C3F1Q37643655-41E425BA-DF1A-4FFC-AB3A-7F5BF1D42862Q37656243-6F3D78BA-C32B-4077-8596-5AF626A729F7Q37907967-2C252C1C-55B9-47C6-B114-9C4E42AA14E1Q37974745-DE678EC5-FC67-44E3-BC1F-E2BBC599AB96Q38001333-1005B00C-7AF9-441E-9DD3-C5780413EECAQ38189330-A720BDCA-3E7B-412E-BE51-8BC05811537DQ38795412-AE64A8BF-C2F5-4A9F-AE4A-690C1F712E4FQ38867552-F9DA8636-9BA5-406F-9F40-2ED3D198B616
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinically significant carbapenemases: an update.
@en
type
label
Clinically significant carbapenemases: an update.
@en
prefLabel
Clinically significant carbapenemases: an update.
@en
P1476
Clinically significant carbapenemases: an update
@en
P2093
Timothy R Walsh
P304
P356
10.1097/QCO.0B013E328303670B
P577
2008-08-01T00:00:00Z